Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Intangibles (2016 - 2025)

Icu Medical's Intangibles history spans 17 years, with the latest figure at $633.6 million for Q4 2025.

  • For the quarter ending Q4 2025, Intangibles fell 14.48% year-over-year to $633.6 million, compared with a TTM value of $633.6 million through Dec 2025, down 14.48%, and an annual FY2025 reading of $633.6 million, down 14.48% over the prior year.
  • Intangibles for Q4 2025 was $633.6 million at Icu Medical, down from $664.8 million in the prior quarter.
  • The five-year high for Intangibles was $1.1 billion in Q1 2022, with the low at $188.3 million in Q4 2021.
  • Average Intangibles over 5 years is $723.7 million, with a median of $795.8 million recorded in 2024.
  • Year-over-year, Intangibles soared 469.73% in 2022 and then fell 15.4% in 2025.
  • Tracing ICUI's Intangibles over 5 years: stood at $188.3 million in 2021, then skyrocketed by 421.88% to $982.8 million in 2022, then fell by 11.41% to $870.6 million in 2023, then dropped by 14.91% to $740.8 million in 2024, then dropped by 14.48% to $633.6 million in 2025.
  • Per Business Quant, the three most recent readings for ICUI's Intangibles are $633.6 million (Q4 2025), $664.8 million (Q3 2025), and $698.0 million (Q2 2025).